140 related articles for article (PubMed ID: 38653183)
1. Clinical and Molecular Characteristics of Neuronal Ceroid Lipofuscinosis in Saudi Arabia.
Saleh MM; Hamhom AM; Al-Otaibi A; AlGhamdi M; Housawi Y; Aljadhai YI; Alameer S; Almannai M; Jad LA; Alwadei AH; Tabassum S; Alsaman A; AlAsmari A; Al Mutairi F; Althiyab H; Bashiri FA; AlHumaidi S; Alfadhel M; Mink JW; AlHashim A; Faqeih EA;
Pediatr Neurol; 2024 Jun; 155():149-155. PubMed ID: 38653183
[TBL] [Abstract][Full Text] [Related]
2. Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers.
Kozina AA; Okuneva EG; Baryshnikova NV; Kondakova OB; Nikolaeva EA; Fedoniuk ID; Mikhailova SV; Krasnenko AY; Stetsenko IF; Plotnikov NA; Klimchuk OI; Popov YV; Surkova EI; Shatalov PA; Rakitko AS; Ilinsky VV
Mol Genet Genomic Med; 2020 Jul; 8(7):e1228. PubMed ID: 32412666
[TBL] [Abstract][Full Text] [Related]
3. A first CLN6 variant case of late infantile neuronal ceroid lipofuscinosis caused by a homozygous mutation in a boy from China: a case report.
Sun G; Yao F; Tian Z; Ma T; Yang Z
BMC Med Genet; 2018 Oct; 19(1):177. PubMed ID: 30285654
[TBL] [Abstract][Full Text] [Related]
4. A needle in a haystack? The impact of a targeted epilepsy gene panel in the identification of a treatable but rapidly progressive metabolic epilepsy: CLN2 disease.
Lourenço CM; Sallum JMF; Pereira AM; Girotto PN; Kok F; Vilela DRF; Barron E; Pessoa A; Oliveira BM
Arq Neuropsiquiatr; 2024 May; 82(5):1-8. PubMed ID: 38763144
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
[TBL] [Abstract][Full Text] [Related]
6. Neuronal ceroid lipofuscinoses type 8: Expanding genotype/phenotype diversity-first report from Saudi Arabia.
Alkhars FZ; Bo Ali AY; Almohanna MA; Almajhad NA
Neurosciences (Riyadh); 2020 Jan; 25(1):65-69. PubMed ID: 31982899
[TBL] [Abstract][Full Text] [Related]
7. Chorea in Late-Infantile Neuronal Ceroid Lipofuscinosis: An Atypical Presentation.
Saini AG; Sankhyan N; Singhi P
Pediatr Neurol; 2016 Jul; 60():75-8. PubMed ID: 27343025
[TBL] [Abstract][Full Text] [Related]
8. Neuronal Ceroid Lipofuscinosis Type 6 (CLN6) clinical findings and molecular diagnosis: Costa Rica's experience.
Badilla-Porras R; Echeverri-McCandless A; Weimer JM; Ulate-Campos A; Soto-Rodríguez A; Gutiérrez-Mata A; Hernández-Con L; Bogantes-Ledezma S; Balmaceda-Meza A; Brudvig J; Sanabria-Castro A
Orphanet J Rare Dis; 2022 Jan; 17(1):13. PubMed ID: 35012600
[TBL] [Abstract][Full Text] [Related]
9. Cynomolgus macaque model of neuronal ceroid lipofuscinosis type 2 disease.
Munesue Y; Ageyama N; Kimura N; Takahashi I; Nakayama S; Okabayashi S; Katakai Y; Koie H; Yagami KI; Ishii K; Tamaoka A; Yasutomi Y; Shimozawa N
Exp Neurol; 2023 May; 363():114381. PubMed ID: 36918063
[TBL] [Abstract][Full Text] [Related]
10. Variant late infantile neuronal ceroid lipofuscinosis (CLN6 gene) in Saudi Arabia.
Al-Muhaizea MA; Al-Hassnan ZN; Chedrawi A
Pediatr Neurol; 2009 Jul; 41(1):74-6. PubMed ID: 19520283
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population.
Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG
J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825
[TBL] [Abstract][Full Text] [Related]
12. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland.
Moore SJ; Buckley DJ; MacMillan A; Marshall HD; Steele L; Ray PN; Nawaz Z; Baskin B; Frecker M; Carr SM; Ives E; Parfrey PS
Clin Genet; 2008 Sep; 74(3):213-22. PubMed ID: 18684116
[TBL] [Abstract][Full Text] [Related]
13. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.
Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN
Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312
[TBL] [Abstract][Full Text] [Related]
14. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
[TBL] [Abstract][Full Text] [Related]
15. Homozygous missense TPP1 mutation associated with mild late infantile neuronal ceroid lipofuscinosis and the genotype-phenotype correlation.
Chen ZR; Liu DT; Meng H; Liu L; Bian WJ; Liu XR; Zhu WW; He Y; Wang J; Tang B; Su T; Yi YH
Seizure; 2019 Jul; 69():180-185. PubMed ID: 31059981
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.
Zhong N; Moroziewicz DN; Ju W; Jurkiewicz A; Johnston L; Wisniewski KE; Brown WT
Genet Med; 2000; 2(6):312-8. PubMed ID: 11339651
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.
Biswas A; Krishnan P; Amirabadi A; Blaser S; Mercimek-Andrews S; Shroff M
AJNR Am J Neuroradiol; 2020 Oct; 41(10):1930-1936. PubMed ID: 32855186
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations.
Panjeshahi S; Karimzadeh P; Movafagh A; Ahmadabadi F; Rahimian E; Alijanpour S; Miryounesi M
Hum Genet; 2023 Aug; 142(8):1001-1016. PubMed ID: 37074398
[TBL] [Abstract][Full Text] [Related]
19. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.
Yu F; Liu XM; Chen YH; Zhang SQ; Wang K
Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
